Spravato for Depression: How It Works, Who It’s For, and What It Actually Feels Like
There's a particular kind of suffering that comes not just from depression—but from trying to treat depression and failing.
You've done the work. You've tried the medications. You've sat in the therapy sessions, made the lifestyle changes, done everything you were told to do. And the depression is still there. Maybe lighter. Maybe not.
This is where treatment-resistant depression lives. And it's more common than most people realize—roughly one in three people with major depression don't respond adequately to standard antidepressant treatment.
For years, the options were limited: try another medication, adjust the dose, wait longer, try again.
Spravato changes that equation.
What Is Spravato—and Why Is It Different?
Spravato is the brand name for esketamine, a derivative of ketamine that's FDA-approved specifically for treatment-resistant depression (TRD) and for major depressive disorder (MDD) with suicidal ideation.
That distinction matters. This isn't a medication that got repurposed. It was studied, approved, and designed for the people who fall through the cracks of conventional care.
What makes it genuinely different isn't just the compound—it's the mechanism.
Every standard antidepressant on the market works on the same basic pathway: serotonin, dopamine, or norepinephrine. Adjust the levels, wait six weeks, hope for the best.
Spravato doesn't touch any of those.
It targets the glutamate system—specifically NMDA receptors—which plays a central role in how neurons communicate and, crucially, how the brain rewires itself. Instead of tweaking the same chemistry that may have already failed, it opens a completely different door.
The Neuroplasticity Window
Here's the core concept that makes Spravato so significant—and so different from anything that came before it.
Depression isn't just low mood. On a neurological level, it's often characterized by rigidity—entrenched patterns of thought, emotion, and neural activity that have become hardwired over time. The brain gets stuck in its loops. The same thoughts, the same responses, the same suffering, reliably triggered by the same cues.
This is why insight alone often isn't enough. You can understand the pattern perfectly and still be trapped in it. Because the pattern isn't just a thought—it's a physical structure in the brain.
Spravato works by rapidly increasing glutamate signaling, which triggers a surge in neuroplasticity. The brain becomes, temporarily, more adaptable. More malleable. More capable of forming new connections and loosening old ones.
Researchers describe this as a "window of neuroplastic flexibility." The rigid scaffolding softens. And in that window, change—real, structural change—becomes more possible.
This is why timing matters. What happens during and after a Spravato session isn't incidental. The brain is in a state where it's unusually open to new experiences. That's both the mechanism and the opportunity.
Why It Works Fast
This might be the most striking thing about Spravato for people who've been through the antidepressant treadmill:
Some people feel a shift within hours.
Not weeks. Hours.
For someone who has spent years waiting for medications to work—or watching them stop working—that kind of timeline can feel almost incomprehensible.
It doesn't happen for everyone, and it's not a cure. But the speed is real, it's documented, and it reflects the fundamentally different way Spravato interacts with the brain. You're not slowly adjusting a chemical baseline over six weeks. You're triggering a rapid neurological response.
What a Spravato Session Actually Feels Like
This is worth being honest about, because it's unlike anything in standard psychiatric care.
Spravato isn't taken at home. It's administered as a nasal spray in a certified medical setting, under supervision, with a required two-hour monitoring period afterward. You cannot drive yourself home.
During the session—which unfolds over 40 to 60 minutes—the experience can include:
A sense of dissociation. Altered perception of time and space. A feeling of distance from your thoughts and the weight they usually carry. Mental quiet.
For many people, this is the most immediately striking part. The mind that has been relentlessly self-critical, anxious, or overwhelmed becomes—for a period—quieter. Less attached to its own stories.
For people who have never experienced that kind of mental relief, it can be genuinely revelatory.
For others, especially early on, it can feel disorienting. The dissociation is unfamiliar. The altered state takes getting used to.
This is precisely why the setting matters—and why what you do with the experience afterward matters even more.
Who Spravato Is For
Spravato is not a first-line treatment. It's designed for a specific population:
People who have tried at least two antidepressants without adequate response. People living with treatment-resistant depression. People experiencing major depression with active suicidal ideation.
This positioning is important. It's not here to replace conventional care—it's here for the people conventional care hasn't helped.
Not everyone is a candidate. Certain medical conditions (uncontrolled hypertension, specific psychiatric histories) can affect eligibility, and a healthcare provider evaluates all of this before treatment begins. Spravato is not a casual intervention. It's a structured, supervised clinical treatment.
The Gap Between Sessions and Lasting Change
Here's the piece that most conversations about Spravato underemphasize—and it may be the most important.
The neuroplastic window Spravato opens is real. But a window doesn't automatically fill itself.
What happens in the hours and days after a session shapes how much of that potential actually becomes lasting change. The brain is more receptive than usual. More open to rewiring. But it still needs something to rewire toward.
This is where integration practices become essential.
Therapy in the days following treatment. Somatic work. Breathwork. Regulation practices. Whatever helps the nervous system consolidate a new experience of safety, openness, or relief rather than letting the old patterns simply reassert themselves.
Tools like SoundSelf are particularly relevant here—not as a medical intervention, but as a way of giving the nervous system repeated experiences of the regulated, expansive state that Spravato briefly makes accessible. The more the nervous system encounters that state, the more it begins to recognize it as familiar. As possible. Eventually, as a baseline.
The medication opens the window. Integration is how you climb through it.
What Spravato Costs—and What Insurance Covers
This is a practical reality worth addressing directly.
Spravato is expensive. Without insurance, a single session can cost several hundred dollars, and the initial treatment protocol involves multiple sessions per week.
The good news: because it's FDA-approved, many insurance plans—including Medicare and Medicaid—cover it for qualifying patients. Coverage varies, and prior authorization is usually required. A certified treatment center can typically help navigate the insurance process.
If cost is a barrier, it's worth exploring before writing it off entirely.
A Different Model of Treatment
Spravato represents something more than a new medication. It reflects a fundamental shift in how depression is understood.
The old model was purely chemical: adjust the levels, restore the balance, wait. The implicit assumption was that depression is primarily a deficiency—of serotonin, of dopamine—and that correcting that deficiency is the goal.
That model has helped many people. It hasn't helped enough.
The emerging model is different. It says that depression is, in significant part, a problem of rigidity—of a nervous system and brain that has organized around pain and can't find its way out. And that healing means creating the conditions for the system to reorganize—around safety, openness, and new possibility.
This is why the most interesting work in mental health right now—Spravato, psychedelic-assisted therapy, somatic approaches, immersive regulation technologies—all point toward the same insight: you can't think your way out of a physiological pattern. The system has to be brought into a different state, and given the conditions to learn from it.
Spravato does this through neurochemistry. Psychedelic therapy does it through altered states. Somatic practice does it through the body. These aren't competing approaches—they're different entry points into the same territory.
Conclusion: Not a Last Resort. A Different Kind of First Step.
If you've been living with treatment-resistant depression—if you've tried the medications, done the work, and still found yourself stuck—Spravato isn't a sign that something is wrong with you. It's a signal that you may need a different kind of intervention.
One that doesn't just adjust your chemistry, but opens your brain to the possibility of change.
That's rare. That's worth taking seriously.
The path forward isn't just about finding the right medication. It's about creating the conditions—neurologically, psychologically, somatically—in which healing can actually take root.
Spravato can be part of that. Not as a silver bullet. As a door.
What you build once you walk through it is still up to you.
FAQs
How fast does Spravato work for depression? Some people notice significant shifts within hours to days of their first session—much faster than traditional antidepressants, which typically take 4–6 weeks.
Is Spravato the same as ketamine therapy? Related, but distinct. Spravato uses esketamine (a derivative of ketamine) and is specifically FDA-approved for treatment-resistant depression. Other ketamine infusion therapies may be offered off-label by clinics.
Can I take Spravato at home? No. It must be self-administered in a certified medical facility under supervision, with a mandatory two-hour monitoring period afterward. You'll also need someone to drive you home.
Why does what I do after a Spravato session matter? Spravato opens a window of neuroplasticity—the brain is temporarily more receptive to change. Integration practices (therapy, somatic work, nervous system regulation) help consolidate that openness into lasting shifts rather than letting old patterns simply reassert themselves.
Is Spravato covered by insurance? Often yes, for qualifying patients. It's FDA-approved, and many insurance plans including Medicare and Medicaid cover it. Prior authorization is typically required.
Is Spravato safe? It's considered safe when administered under medical supervision as directed. Potential side effects include temporary dissociation, dizziness, or nausea during or after sessions—which is why in-clinic administration and monitoring is required.